SEC Form 4 · accession 0001193125-26-354021
MDxHealth SA · MDXH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 13, 2026
Accepted (ET)
Aug 17, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001872529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Aug 13, 2026 | P | 2,202,643 | $0.454 | A | 6,903,100 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ordinary shares, no par value, of MDxHealth SA (the "Issuer") purchased pursuant to securities purchase agreements by and between the Issuer and certain private investment vehicles managed by MVM Partners, LLC (the "Funds"), each dated as of August 11, 2026.
- F2The securities reported herein are directly owned by the Funds. The securities may also be deemed beneficially owned by MVM Partners, LLC ("MVM") as the investment manager of the Funds and by Eric Bednarski as Managing Member of MVM. Each of Mr. Bednarski and MVM disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interests therein, if any, and this Form 4 shall not be deemed an admission that either Mr. Bednarski or MVM is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.